Related Experiment Video
Updated: Aug 3, 2026
14:09
Genetic Studies of Human DNA Repair Proteins Using Yeast as a Model System
Published on: March 18, 2010
Identification of partial loss of function p53 gene mutations utilizing a yeast-based functional assay
G K Kovvali1, B Mehta, C B Epstein
1Departments of Medicine and Biochemistry, Robert Wood Johnson Medical School and The Cancer Institute of New Jersey, University of Medicine and Dentistry of New Jersey, New Brunswick, NJ 08901, USA.
Nucleic Acids Research
|February 27, 2001
Summary
Researchers developed a new yeast assay to identify partial loss-of-function p53 mutants, which are common in cancer. This tool helps detect cancer-associated p53 gene mutations that retain some transcriptional activity.
Area of Science:
- Molecular biology
- Cancer research
- Genetics
Background:
- Missense mutations in the p53 tumor suppressor gene's DNA binding region are frequent in human cancers.
- Hot-spot p53 mutants, accounting for 30% of mutations, typically lack transcriptional activity.
- Emerging evidence suggests some non-hot-spot p53 mutants retain partial transcriptional activity in vivo.
Purpose of the Study:
- To develop and validate a modified yeast-based functional assay for identifying partial loss-of-function p53 mutants.
- To efficiently detect p53 mutants with residual transcriptional activity, particularly those not at hot-spot locations.
Main Methods:
- Modification of a previously established yeast-based p53 functional assay.
- Testing the assay's utility with a diverse panel of p53 mutants, including known hot-spot and non-hot-spot variants.
Main Results:
- The modified yeast assay successfully identified partial loss-of-function p53 mutants.
- The assay demonstrated its capability to distinguish between mutants with complete and partial loss of transcriptional activity.
Conclusions:
- A modified yeast functional assay is effective for identifying p53 mutants with partial loss of function.
- This assay provides a valuable tool for studying the diverse functional consequences of p53 mutations in cancer.
